Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
38.66
-0.30 (-0.78%)
At close: Nov 20, 2026, 4:00 PM EST
38.64
-0.02 (-0.04%)
After-hours: Nov 20, 2026, 7:53 PM EST
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $28.01 billion as of November 20, 2026. It is the 839th most valuable company in the world and the 369th biggest in the United States. Its market cap has increased by 97.99% in one year.
Market Cap
28.01B
Enterprise Value
23.91B
1-Year Change
97.99%
Global Rank
Country Rank
#369 United States
Category
ChartMarket Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $28.01B, an increase of 5,151.06%. That is a compound annual growth rate of 94.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 28.01B | 85.58% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 45.66B |
| Royalty Pharma | 38.84B |
| Revolution Medicines | 34.48B |
| Genmab | 32.50B |
| Insmed | 31.69B |
| Incyte | 23.62B |
| BioNTech SE | 20.18B |
| Alnylam Pharmaceuticals | 19.80B |